SMN Pharma Private Limited
About SMN Pharma Private Limited
Data last updated:
SMN Pharma Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24231TN2020PTC134996.
The company has an authorised share capital of ₹17.1 Cr and a paid-up capital of ₹14.02 Cr. It is led by directors Navin Bafna and Sasikala Bafna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.96 Avadhanam Papier Road 4th Floor Choolai, Chennai, Tamil Nadu, India – 600112.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.27 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹5.78 Lakh (net margin 33.5%) and EBITDA of ₹7.36 Lakh (EBITDA margin 42.6%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years.
Company details
Contact details
SMN Pharma Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.96 Avadhanam Papier Road 4th Floor Choolai, Chennai, Tamil Nadu, India – 600112
- IndustryPharma, Drug Formulation & Development
To see the full contact details of SMN Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of SMN Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of SMN Pharma Private Limited
FY 2025 filings availableSMN Pharma Private Limited reported revenue of ₹17.27 Lakh (up 393% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 393% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 14%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.78 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 42.6% | ||||
| Net Profit Margin | 33.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of SMN Pharma Private Limited, buy the company report.
Board of directors of SMN Pharma Private Limited
SMN Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Navin Bafna Also directs: Saffolco Pharmachem LLP | Director | 20 Mar 2020 | 6 Years 7 Months | Current |
| Sasikala Bafna | Director | 20 Mar 2020 | 6 Years 7 Months | Current |
Peer comparison
SMN Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SRS Therapeutics Private Limited | ₹17.38 Lakh (FY 2021) | 234.0% | Mumbai, Maharashtra, India | |||
| SMN Pharma Private Limitedthis company | ₹17.27 Lakh (FY 2025) | ₹5.78 Lakh | 33.5% | 393.0% | Chennai, Tamil Nadu, India | |
| Maverick Pharma Private Limited | ₹17.17 Lakh (FY 2025) | -72.0% | Delhi, India | |||
| Metsun Pharma India Private Limited | ₹17.11 Lakh (FY 2018) | Aurangabad, Maharashtra, India |
To see the full peer comparison of SMN Pharma Private Limited, buy the company report.
Auditor
SMN Pharma Private Limited is audited by Soleti Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Soleti Associates | FY 2023 | 006148S |
Shareholding
The shareholding of SMN Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of SMN Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving SMN Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for SMN Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
SMN Pharma Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
No GST registration is on our record for SMN Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
SMN Pharma Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Navin Bafna ceased to be Director on 29 Dec 2021.
Frequently asked questions
SMN Pharma is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 March 2020 (6+ years old) and is registered under CIN U24231TN2020PTC134996.
SMN Pharma has 2 current directors:
- Navin Bafna - Director
- Sasikala Bafna - Director
The latest financial statements of SMN Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of SMN Pharma is U24231TN2020PTC134996. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SMN Pharma was incorporated on 20 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of SMN Pharma by revenue are SRS Therapeutics Private Limited, Maverick Pharma Private Limited, Metsun Pharma India Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Navin Bafna ceased to be Director on 29 Dec 2021. Sasikala Bafna ceased to be Director on 29 Dec 2021. Navin Bafna was appointed as Director on 20 Mar 2020. SMN Pharma has 4 board changes on record in total.
The registered office of SMN Pharma is at No.96 Avadhanam Papier Road 4th Floor Choolai, Chennai, Tamil Nadu, India – 600112.
SMN Pharma operates in the pharma industry, in the drug formulation and development segment.
SMN Pharma can be reached at its registered office: No.96 Avadhanam Papier Road 4th Floor Choolai, Chennai, Tamil Nadu, India – 600112.
SMN Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Chennai.